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Abstract  Dexmedetomidine  is  a  highly  selective  -2  agonist  which  has  recently  revolutionized
our anesthesia  and  intensive  care  practice.  An  obstetric  patient  presented  for  emergency  cae-
sarean delivery  under  general  anesthesia,  with  pre-eclampsia  and  postpartum  hemorrhage.  In
carefully selected  cases  with  refractory  hypertension  and  postpartum  hemorrhage,  dexmedeto-
midine can  be  used  for  improving  overall  patient  outcome.  It  was  beneﬁcial  in  controlling  both
the blood  pressure  and  uterine  bleeding  during  caesarean  section  in  our  patient.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
PALAVRAS-CHAVE
Dexmedetomidina;
Anestesia  obstétrica;
Hipertensão  induzida
pela  gravidez;
Hemorragia
pós-parto;
Cesariana  de
Hemorragia  pós-parto  e  hipertensão  induzida  pela  gravidez  durante  cesariana  de
emergência  em  segmento  uterino  inferior:  dexmedetomidina  em  nosso  socorro
Resumo  Dexmedetomidina  é  um  2-agonista  altamente  seletivo  que  recentemente  revolu-
cionou a  nossa  anestesia  e  a  prática  de  tratamento  intensivo.  Uma  paciente  obstétrica  admitida
para cesariana  de  emergência  sob  anestesia  geral,  com  pré-eclâmpsia  e  hemorragia  pós-parto.
Em casos  cuidadosamente  selecionados  com  hipertensão  refratária  e  hemorragia  pós-parto,
dexmedetomidina  pode  ser  usada  para  melhorar  o  resultado  geral  da  paciente.  O  fármaco  foiemergência benéﬁco no  controle  tanto  da  pressão  arterial  quanto  do  sangramento  uterino  durante  cesariana
em nossa  paciente.
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ntroduction
ver  since  dexmedetomidine  has  been  approved  for  human
se  by  the  FDA  in  1999,  its  indications  and  ramiﬁcations
n  anesthesia  and  intensive  care  has  been  increasing.  Its
se  in  obstetric  anesthesia  has  been  delayed  due  concerns
egarding  maternal  and  fetal  effects.  In  view  of  its  sev-
ral  advantageous  effects,  it  has  been  used  in  caesarean
ections  for  controlling  blood  pressure  response  to  intu-
ation  and  as  an  alternative  agent  for  labor  analgesia  as
n  IVPCA  (intravenous  patient  controlled  analgesia).  We
resent  a  case  of  PIH  for  emergency  caesarean  section  under
eneral  anesthesia,  where  dexmedetomidine  was  used  to
ontrol  her  refractory  hypertension,  uterotonicity,  stabilize
emodynamics,  prevention  of  postoperative  shivering  and
upplement  postoperative  analgesia.
ase report
 30  year  old,  70  kg,  primigravida  presented  to  the  obstet-
ic  emergency  in  labor,  with  uncontrolled  blood  pressure
nd  non-reassuring  fetal  heart  rate  at  38  weeks  period  of
estation.  She  was  a  diagnosed  case  of  pregnancy  induced
ypertension  (PIH)  on  alpha-methyl-dopa  therapy.  She  was
osted  for  emergency  caesarean  section  in  view  of  persis-
ent  fetal  decelerations.  The  patient  refused  any  kind  of
euraxial  block  in  view  of  previous  back  surgery  for  lumbar
lipped  disk  and  recurrent  back  ache  since  2  years.  On  preop-
rative  evaluation,  blood  pressure  (B.P)  was  200/102  mmHg;
ulse  rate  was  120  beats  per  minute,  regular,  normal  vol-
me;  bilateral  pedal  edema  was  present  with  no  evidence
f  congestive  cardiac  failure.  Intravenous  (I.V.)  Magnesium
ulphate  therapy  was  started  preoperatively  by  the  obste-
ricians  for  seizure  prophylaxis.  There  were  no  signs  of  CNS
Central  Nervous  System)  irritation,  visual  defects,  coag-
lopathy  or  renal  dysfunction.  Invasive  arterial  line  was
nstituted  pre-induction  for  beat-to-beat  pressure  monitor-
ng.  Due  to  patient  refusal,  standard  general  anesthesia
ith  preoxygenation,  rapid  sequence  induction  and  cricoids
ressure  was  planned  after  aspiration  prophylaxis  and
ppropriate  monitoring.  To  minimize  hypertensive  response
o  laryngoscopy  and  intubation,  I.V.  preservative  free  Lig-
ocaine  hydrochloride  2%  (2  mL)  and  I.V.  Labetolol  infusion
5  mg/min)  were  given.  Modiﬁed  Cormack  and  Lehane  grad-
ng  was  2B.
Despite  all  the  above  measures  and  single  attempt  gentle
aryngoscopic  intubation,  the  B.P  was  not  controlled.  Post
ntubation  B.P.  was  198/100  mmHg  and  Pulse  rate  118  min,
hen  O2+ N2O+ Isoﬂurane  inhalational  agent  were  started  for
aintenance  of  anesthesia.  Induction  delivery  interval  was
 min.  Immediately  on  cord  clamping,  loading  dose  (70  g/h
ver  10  min)  of  dexmedetomidine  (Dexmed)  was  started,  fol-
owed  by  maintenance  dose  of  35  g/h  I.V.  infusion  (along
ith  syntocinon  infusion).  B.P  and  pulse  rate  started  to  sta-
ilize  and  normalize.
Delivery  of  the  baby  and  placenta  was  followed  by  post-
artum  hemorrhage  (PPH).  Despite  meticulous  attentionPlease  cite  this  article  in  press  as:  Hariharan  U.  Postpar
during  emergency  lower  segment  caesarean  section:  dexme
http://dx.doi.org/10.1016/j.bjane.2014.12.002
o  hemostasis,  syntocinon  infusion,  decreasing  inhalational
nesthetic  agent  and  prostadin  injection,  uterine  bleeding
as  not  controlled.  Dexmed  also  has  uterotonic  effects,
hich  was  beneﬁcial  in  controlling  this  PPH.  Once  B.P
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as  controlled  and  the  uterus  contracted  after  Dexmed
nfusion,  uterine  bleeding  was  also  controlled.  The  apgar
cores  of  the  baby  were  normal  at  birth,  1  and  5  min.
fter  ensuring  adequate  hemostasis,  followed  by  uterine
nd  skin  closure,  preparations  for  reversal  and  extubation
ere  made.  Dexmed  infusion  was  continued  on  maintenance
ose.  On  return  of  spontaneous  respiration  and  train-of-  four
esponses  on  neuromuscular  monitoring,  reversal  was  given
nd  the  patient  extubated  when  fully  awake.
Patient  maintained  her  vitals  well  and  her  postoperative
.P  was  132/80  mmHg  and  pulse  rate  88  beats/min.  Pain
anagement  was  done  with  multi-modal  analgesia  (intra-
enous  paracetamol  infusion  1  g,  intramuscular  diclofenac
njection  75  mg  and  incision  site  local  anesthetic  inﬁltration)
long  with  Dexmed  infusion  (@30  mcg/h).
Patient  was  shifted  to  a high  dependency  care  unit  for
bservation  and  monitoring.  After  2  h,  Dexmed  infusion  was
lowly  tapered-off  and  stopped  after  1  h.  In  the  mean-
hile,  her  B.P  remained  within  normal  limits.  After  stopping
exmed  infusion,  B.P.  was  controlled  with  low  dose  intra-
enous  labetolol  (5  mg  slow  I.V.  boluses  over  1  min)  as  and
hen  required  (labetolol  was  required  only  twice  in  24  h)
nd  later  with  oral  amlodepine  (10  mg  twice  daily  from  next
ay).  The  newborn  was  put  to  breast  feeding  within  4  h  of
irth  and  taken  care-off  in  the  nursery.  Patient  was  shifted  to
ard  with  normal  vitals  the  next  day  (after  removing  arte-
ial  line)  and  later  discharged,  with  oral  antihypertensive
herapy  and  advised  for  regular  follow-up  with  the  obstetri-
ian.
iscussion
exmedetomidine  hydrochloride  (Dexmed)  is  a  highly  selec-
ive  -2  receptor1 agonist  (-1  to  -2  ratio  is  1:1600)  with
arious  applications  in  anesthesia  and  intensive  care.  It  is
he  S-enantiomer  of  medetomidine,2 with  empirical  formula
13H16N2.
It  is  given  in  a  loading  dose3 of  1  g/kg/h  over
0  min,  followed  by  maintenance  intravenous  infusion  of
.2--0.7  g/kg/h.  It  produces4 sedation,  sympatholysis,  car-
iovascular  stability,  anxiolysis,  analgesia,  neuroprotection
nd  anesthesia-sparing  effects.  Its  purported  advantages5
nclude  minimal  respiratory  depression,  renoprotection,
uick  offset  and  cardioprotection.  The  main  side  effects
nclude  dry  mouth,  nausea,  hypotension  and  bradycardia.
ts  reluctant  use  in  obstetrics  is  due  to  concerns  regarding
ossible  maternal  and  fetal  effects.6 Dexmed  is  lipophilic
nd  its  placental  extraction  is  high.  Hence  its  fetal  trans-
er  through  the  placenta  is  minimal.  In  animal  experiments,
exmed  has  not  been  found  to  cause  adverse  fetal  effects.7
t  has  been  used  in  obstetrics  for  control  of  B.P  during
aesarean  section  and  for  labor  analgesia.  Isolated  case
eports  have  asserted  the  safety  of  Dexmed  in  obstetric
nesthesia.8 Our  case  report  highlights  the  usefulness  of
exmed  in  controlling  refractory  hypertension  in  patients
ith  PIH.  It  also  emphasizes  the  unmatched  role  of  Dexmed
n  cardiovascular  stability  during  caesarean  section  undertum  hemorrhage  and  pregnancy  induced  hypertension
detomidine  to  our  rescue.  Rev  Bras  Anestesiol.  2015.
eneral  anesthesia.  One  unique  aspect  brought  to  light  in
his  case  is  the  uterotonic9 effect  of  Dexmed.  The  uterine
leeding  got  controlled  only  after  starting  Dexmed  infusion.
PH  is  a  devastating  complication  during  delivery.  We  did  not
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Postpartum  hemorrhage  and  pregnancy  induced  hypertensio
prefer  using  nitroglycerine  for  B.P  control  due  to  its  uterine
relaxant  effects.
Inhalational  anesthetics  could  also  confound  PPH,  hence
Isoﬂurane  concentration  was  decreased  on  starting  Dexmed
infusion.  Once  the  B.P  was  controlled  with  Dexmed,  the
bleeders  also  stopped  oozing.  Timely  control  of  PPH  is  this
case  could  be  due  to  the  combined  effects  of  B.P  control
and  uterotonicity.  This  uterotonic  effect  of  Dexmed  needs
to  be  investigated  and  researched  further.  Blood  transfusion
and  its  attendant  complications  could  be  avoided  in  patients
with  PPH.  Analgesia  was  also  supplemented  by  Dexmed  infu-
sion  both  intra-  and  postoperatively.  Her  hypertension  was
also  under  control  in  the  postoperative  period.  Dexmed  was
used  only  after  cord  clamping,  so  the  question  of  fetal
effects  does  not  arise  in  this  case,  as  highlighted  by  the
normal  apgar  scores.  Invasive  arterial  and  neuromuscular
monitoring  was  used  along  with  other  standard  monitoring
devices  in  this  patient.  She  also  was  observed  postopera-
tively  in  an  intensive  care  unit  for  24  h  and  then  transferred
out.
Conclusions
Though  it  is  too  ambitious  to  routinely  recommend  the  use
of  dexmedetomidine  in  obstetric  anesthesia,  its  unparalled
multipurpose  use  in  sedation,  cardiovascular  stability,  anal-
gesia  and  blood  pressure  control  cannot  be  ignored.  We  need
to  be  cautious  as  there  is  a  possibility  of  maternal  hypoten-
sion  and  fetal  bradycardia.
Since  its  placental  extraction  is  high,  its  fetal  effects
are  usually  negligible.  Its  placental  retention  ratio  is  high
(Maternal  to  Fetal  Index/Ratio  0.77)  and  it  also  directly
potentiates  the  amplitude  and  rate  of  uterine  contractions.
Its  uterotonic  effect  and  efﬁcacy  in  PPH,  needs  to  be  studiedPlease  cite  this  article  in  press  as:  Hariharan  U.  Postpar
during  emergency  lower  segment  caesarean  section:  dexme
http://dx.doi.org/10.1016/j.bjane.2014.12.002
further  in  large  randomized  trials  before  being  put  to  tangi-
ble  clinical  use.  In  carefully  selected  cases  with  refractory
hypertension  and  post-partum  hemorrhage,  dexmedetomi-
dine  can  be  used  for  improving  overall  patient  outcome.  It
9 PRESS
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as  beneﬁcial  in  controlling  both  the  blood  pressure  and
terine  bleeding  during  caesarean  section,  as  well  as  for
nalgesia  in  our  patient.  Such  cases  of  patient  refusal  or
ome  relative  contraindication  to  regional  anesthesia  for
mergency  operative  delivery  may  pose  a challenge  for  the
naesthesiologists,  especially  when  complicated  by  PIH  or
PH.
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